Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer

Abstract

Our data suggest that there may be differences in tumor phenotypes within the HER2/neu-overexpressing breast cancer patients. The overexpression of pAkt may be a powerful prognostic marker for predicting DFS and overall survival of breast cancer patients.